An unexpected publication in the urology literature is an article analyzing the ways in which selected major media reported on the results of the Prostate Lung Colorectal Ovarian Cancer (PLCO) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) trials after their publication in the New England Journal of Medicine in early 2009. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: ERSPC, media, PLCO, screening | 2 Comments »
It is well-understood that a problem with the data from the PLCO screening trial was that many men in the “control” (supposedly non-screened) arm of the trial did in fact get PSA testing and have DREs during the time period of the trial (albeit outside the trial protocol and not at the trial centers). But how bad was that “contamination” of the trial data? … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PLCO, screening, testing | 8 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 